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Abstract Objectives The aim of this study was to
evaluate the effects of alcohol septal ablation (ASA)
on coronary blood flow in symptomatic hypertrophic
obstructive cardiomyopathy (HOCM) using cardiac
MR (CMR) coronary flow measurements. Back-
ground CMR flow mapping enables quantification
of coronary blood flow in a noninvasive way. Both
left ventricular outflow tract (LVOT) gradient reduc-
tion and myocardial scarring after ASA are expected
to influence left anterior descending (LAD) coronary
blood flow. Methods Cine, contrast-enhanced (CE)
imaging and breath-hold CMR phase contrast veloc-
ity mapping were performed at baseline and 1 and
6 months after ASA in seven patients. Changes of
coronary blood flow were related to left ventricular
(LV) mass reduction, enzyme release, volume of
ethanol administered, LVOT gradient reduction, and
LV rate pressure product (LVRPP). Results A
significant mass reduction was observed both in the
target septal myocardium and in the total myocar-
dium (both P \ 0.01). Mean myocardial infarct size
was 23 ± 12 g (range 7.3–41.6 g). LVRPP decreased
from 13,268 ± 2,212 to 10,685 ± 3,918 at 1 month
(P = 0.05) and 9,483 ± 2,496 mmHg beats/min at
6 months’ follow-up (P \ 0.01). LAD coronary
blood flow decreased from 100 ± 37 ml/min at
baseline to 84 ± 54 ml/min (P = 0.09) at 1 month
and 67 ± 33 ml/min at 6 months follow-up
(P \ 0.01). A significant correlation was found
between the change in LVRPP and LAD coronary
flow at 1 month follow-up (r = 0.83, P = 0.02). CE-
infarct size tended to modulate the blood flow
changes over time (P = 0.12); no correlation was
observed between enzyme release, volume of ethanol
or both septal and total mass reduction and coronary
blood flow. Conclusion The reduction in coronary
blood flow is primarily associated with diminished
LV loading conditions, whereas the induction of
metabolically inactive myocardial scar tissue by ASA
did not significantly influence the changes in coro-
nary blood flow.
W. G. van Dockum (&)  P. Knaapen 
A. M. Beek  A. C. van Rossum
Department of Cardiology, ICaR-VU, VU University
Medical Center, De Boelelaan 1117, P.O. Box 7057,
1081 HV Amsterdam, The Netherlands
e-mail: wg.vandockum@vumc.nl
M. B. M. Hofman  J. P. A. Kuijer
Department of Physics and Medical Technology,
ICaR-VU, VU University Medical Center,
Amsterdam, The Netherlands
F. J. ten Cate
Department of Cardiology, Thoraxcenter Erasmus
Medical Center, Rotterdam, The Netherlands
J. M. ten Berg
Department of Cardiology, St Antonius Hospital,
Nieuwegein, The Netherlands
J. W. R. Twisk
Department of Clinical Epidemiology and Biostatistics,
VU University Medical Center, Amsterdam,
The Netherlands
123
Int J Cardiovasc Imaging (2009) 25:511–518
DOI 10.1007/s10554-009-9437-2
Keywords Alcohol ablation 
Hypertrophic cardiomyopathy  Perfusion 
Magnetic resonance imaging
Introduction
Hypertrophic cardiomyopathy (HCM) is a primary
cardiac disease characterized by hypertrophy of the
myocardium in the absence of any systemic or other
cardiac disease, which predominantly affects the
interventricular septum [1]. In approximately one
quarter of patients, the disease process of asymmetrical
septal hypertrophy is complicated by left ventricular
outflow tract (LVOT) obstruction due to bulging of the
thickened septum into the outflow tract and abnormal
anterior motion of the mitral valve during systole [2].
The inherent augmented loading conditions result in
increased basal levels of oxygen utilization and
coronary blood flow [3]. Coronary vasodilator reserve
in HCM, however, is impaired due to coronary
microvascular dysfunction. Consequently, metabolic
demand frequently exceeds supply, leading to myo-
cardial ischemia and its related symptoms [4, 5].
Alcohol septal ablation (ASA) has shown to
successfully relieve LVOT obstruction with subse-
quent relief of symptoms in patients with
hypertrophic obstructive cardiomyopathy (HOCM)
[6, 7]. This is achieved by ethanol infusion into septal
branches of the left anterior descending coronary
artery (LAD) resulting in an artificially induced
septal myocardial infarction with regional myocardial
wall thinning and widening of the LVOT [8]. The
decrease of the pressure gradient leads to a reduction
of the left ventricular (LV) end-diastolic pressure and
LV wall stress [9]. Myocardial scarring and reduced
metabolic demand caused by diminished loading
conditions after ASA are expected to influence LAD
blood flow [10]. Data to substantiate this hypothesis,
however, are lacking.
Phase-contrast velocity measurements with cardiac
magnetic resonance imaging (CMR) allows non-
invasive quantification of coronary blood flow [11].
The present study was conducted to serially assess the
impact of ASA on LAD resting blood flow using
CMR phase-contrast imaging. Furthermore, the deter-
minants of flow changes were explored.
Methods
Patients
Patients with HOCM scheduled to undergo ASA and
eligible for CMR imaging were studied. The indica-
tion for ASA was based on a significant left
ventricular outflow tract (LVOT) pressure gradient
as documented by echocardiography and symptoms
(NYHA functional class II-IV), despite medical
treatment. Exclusion criteria were any absolute or
relative contra-indication to CMR imaging (e.g.,
pacemaker, claustrophobia), atrial fibrillation, or
failure to give informed consent. The septal ablation
procedure has been described previously [8]. Results
of the standard CMR protocol in a larger group have
been published elsewhere [8, 12].
Patients underwent phase-contrast velocity mea-
surements in addition to a standard CMR imaging
protocol that included volume and mass measure-
ments and delayed contrast-enhanced imaging prior
to ASA and at 1 and 6 months after treatment. A total
number of 16 patients were included in the study.
Due to imaging artefacts and missing follow-up data,
seven patients completed the study protocol and are
reported in the current paper. One patient with
recurrent symptoms underwent a redo procedure at
4 months after the initial ASA because no successful
gradient reduction was achieved ([50%).
The study protocol was approved by the Commit-
tee on Research Involving Human Subjects and the
Medical Ethics Committee of the VU University
Medical Center, Amsterdam.
Echocardiography
The LVOT pressure gradient was documented by
Doppler echocardiography. In symptomatic patients a
peak pressure gradient C50 mmHg at rest was
considered to be significant. One patient was symp-
tomatic with a resting gradient \50 mmHg. In this
patient, provocation was applied using the Valsalva
maneuver resulting in a pressure gradient during
provocation of C50 mmHg.
CMR image acquisition
CMR was performed at baseline and 1 and 6 months
after ASA on a 1.5 Tesla clinical scanner (Sonata,
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Siemens, Erlangen, Germany), using a four-element
phased-array receiver coil. Cine- and delayed con-
trast-enhanced images were acquired with ECG
gating and during repeated single breath-holds of
10–15 s depending on heart rate, coronary phase
contrast velocity images were acquired using breath
holds of 20–30 s. Cine images were acquired using a
segmented steady-state free precession gradient-echo
sequence in three long-axis views (2-, 3-, and 4-
chamber view) and in multiple short-axis views every
10 mm, covering the entire left ventricle from base to
apex.
Delayed contrast-enhanced (DCE) images were
acquired 15–20 min after intravenous administration
of 0.2 mmol/kg gadolinium-DTPA in the same views
used in cine CMR, using a two-dimensional seg-
mented inversion-recovery prepared gradient-echo
sequence [13]. The DCE images were acquired to
determine infarct size and location after the ablation
procedure and to make sure that the infarct region
was limited to the septum [8].
Coronal and transversal scout images were acquired
to localize the left anterior descending (LAD) artery.
Two-dimensional double oblique coronary angio-
graphic sequence was obtained perpendicular to the
direction of LAD flow with a breath-hold technique
during inspiration. CMR phase contrast velocity
measurements were performed in a plane perpendic-
ular to the proximal LAD within one breath-hold
(spatial resolution 1.2 9 1.4 9 5.5 mm3). A seg-
mented k-space technique was used to obtain
multiple phase-encoding steps (5) for each frame
within the cardiac cycle, resulting in an acquisition
window of 95 ms. Other imaging parameters included
a temporal resolution using echo sharing of 63 ms, a
flip angle of 25, a field of view of 300 9 244 mm2, an
echo time of 3.6 ms and a scan duration of 20 heart
beats. The encoding velocity was set between 40 and
125 cm/s. Heart rate and systemic arterial pressure
were monitored during the imaging procedure.
CMR image analysis
Analysis of cine images
Global LV function parameters, including end-dia-
stolic volume (EDV), end-systolic volume (ESV),
ejection fraction (EF), total and septal myocardial
mass were quantified using standard software (MASS
version5, Medis, Leiden, the Netherlands). Endocar-
dial and epicardial borders were traced manually in
end-diastolic and end-systolic frames of all short-axis
slices. Papillary muscles were included in the
assessment of LV mass. The septum was defined as
the myocardium between the anterior and posterior
junctions of the right ventricle to the LV.
Analysis of contrast-enhanced images
Infarct size after ASA was measured by manual
tracing of the hyperenhanced area within the septal
myocardium with pixel signal intensity (SI) val-
ues [ SI of remote, non-enhanced myocardium ? 4
SD [8]. Central dark zones within the area of
hyperenhancement were included.
Analysis of left anterior descending blood flow
Flow analysis was performed with the standard
software (FLOW, Medis, Leiden, The Netherlands).
The contour of the cross-sectioned LAD was visually
determined on a magnitude image at mid diastole, the
phase of the cardiac cycle in which the highest image
quality was obtained. The area of the region of
interest was kept constant over the cardiac cycle and
repositioned at each time frame on the magnitude
image. The averaged velocities were measured within
each contour on the corresponding phase contrast
image. The velocity of the myocardial motion was
obtained by drawing a contour in the myocardial
tissue close to the vessel of interest. To correct for
cardiac motion the velocity within this contour was
subtracted from the flow velocity within the vessel,
resulting in a net forward velocity. The product of
area and velocity yields instantaneous volumetric
blood flow. Plots were made of phasic velocity and
volume of blood flow versus time in the cardiac cycle
(Fig. 1). Because a prospectively triggered electro-
cardiographic gating technique was used, no
measurements could be obtained during the final
50 ms of the cardiac cycle. Data sets were interpo-
lated over the whole cardiac cycle [11].
Statistical analysis
Results are expressed as mean ± SD. Longitudinal
data analysis was performed using generalized esti-
mating equations (GEE) for serial measurements to
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evaluate the changes in heart rate, systolic (SBP) and
diastolic blood pressures (DBP), septal and total LV
myocardial mass, LV volumes, LVOT pressure
gradient (LVOTG), LV rate pressure product
[LVRPP = (SBP ? LVOTG) 9 heart rate] and
LAD coronary artery blood volume flow from
baseline to 1 and 6 months after ASA. In the GEE-
modeling, time was added as a categorical variable
indicated by dummies. Besides the crude develop-
ment over time, the influence of certain modulating
variables (e.g., amount of ethanol administered,
cardiac enzyme release, infarct size measured by
contrast-enhanced CMR, and serial change in the
LVRPP) was investigated by adding the particular
variables one at the time to the GEE-models in order
to investigate whether the ‘intercept’ of the develop-
ment was influenced. GEE analysis was also used to
estimate the correlation between the changes in LAD
blood volume flow and the changes in septal and total
LV mass, LV volumes, ejection fraction, infarct size
measured by contrast-enhanced CMR, and LVRPP.
Linear regression analysis was used to analyze the
relationship between LAD blood volume flow and the
amount of ethanol administered, cardiac enzyme
release and infarct size measured with contrast-
enhanced CMR. All GEE-analyses were performed
with STATA (version 9); linear regression analyses
were performed with SPSS version 14.0, and signif-
icance was set at a P-value B 0.05.
Results
Mean age was 46 ± 12 years (range 32–64, 5 males).
The mean volume of ethanol injected during the ASA
procedure was 2.9 ± 1.2 ml (range 1.5–5.0 ml). The
mean peak CK and CK-MB release were 1,385 ±
410 U (range 807–1,997 U) and 207 ± 54 U (range
112–292 U), respectively. All patients were receiving
one or more drugs (beta-blockers [n = 5], calcium
channel blockers [n = 5], and antiarrhythmic drugs
[n = 1]), which were kept constant during the follow-
up period.
At baseline, LVOT pressure gradient was
C50 mmHg in six patients (87 ± 11 mmHg; range
52–100 mmHg), and one had a provocable gradient
(26 mmHg at rest, 80 mmHg after Valsalva maneu-
ver). A gradient reduction of more than 50% was
achieved in six patients at a follow-up period of
6 months. All except one patient reported subjective
improvement of exercise tolerance. The mean NYHA
functional class improved significantly from
2.9 ± 0.4 to 1.8 ± 0.9 at 1 month and 1.3 ± 0.7 at
6 months after ASA (P \ 0.01 for trend).
Using delayed contrast-enhanced imaging after the
procedure, septal infarct was demonstrated in all
patients, none of the patients had evidence of infarct-
related hyperenhancement outside the interventricular
septum. Mean myocardial infarct size was 23 ± 12 g
(range 7.3–41.6 g).
Hemodynamic parameters
Changes in hemodynamic parameters are summarized
in Table 1. Compared to baseline, no change was
observed in heart rate, systolic and diastolic arterial
blood pressure at 1 and 6 months after ASA. The
LVOT gradient decreased from 79 ± 25 to
34 ± 48 mmHg at 1 month to 23 ± 35 mmHg at
6 months after the procedure (P \ 0.01). LVRPP
decreased from 13,268 ± 2,212 to 10,685 ± 3,918 at
Fig. 1 Typical example of an anatomical (a) and correspond-
ing velocity encoding CMR image (b) of the LAD coronary
artery at mid-diastole (arrow). The graph represents the
coronary blood flow curve of this patient
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1 month (P = 0.05) and 9,483 ± 2,496 mmHgbeats/
min at 6 months follow-up (P \ 0.01).
LV volumes, ejection fraction, regional mass
CMR derived values of LV volumes, EF, and
regional myocardial mass are listed in Table 1.
Ejection fraction decreased slightly, but significantly
(P \ 0.01), owing to a significant increase in LVESV
(P \ 0.05) over time after treatment. In addition, a
significant mass reduction was observed both in the
target septal myocardium and in the total myocar-
dium (both P \ 0.01).
Correlation between changes in LAD blood flow
and other parameters
LAD coronary blood flow decreased from
100 ± 37 ml/min at baseline to 84 ± 54 ml/min at
1 month (P = 0.09) and 67 ± 33 ml/min at 6 months
follow-up (P \ 0.01; Table 1; Fig. 2). The following
modulators affected development over time: a larger
Table 1 Basal hemodynamics and CMR derived parameters at baseline and after ASA
Baseline 1 month follow-up 6 months follow-up
Hemodynamic parameters
Heart rate 65 ± 5 65 ± 6 64 ± 6
Systolic blood pressure (mmHg) 127 ± 14 130 ± 14 125 ± 18
Diastolic blood pressure (mmHg) 74 ± 13 74 ± 10 76 ± 9
LV outflow gradient (mmHg) 79 ± 25 34 ± 48* 23 ± 35*
LVRPP (*103 mmHgbeats/min) 13,268 ± 2,212 10,685 ± 3,918§ 9,483 ± 2,496*
CMR derived parameters
LAD blood flow (ml/min) 100 ± 37 84 ± 54 67 ± 33*
LV end-diastolic volume (ml) 164 ± 46 167 ± 48 177 ± 37§
LV end-systolic volume (ml) 52 ± 21 54 ± 18 62 ± 19§
LV ejection fraction (%) 69 ± 7 68 ± 4 66 ± 5§
Total LV mass (g) 238 ± 81 220 ± 79 203 ± 76*
Septal mass (g) 77 ± 25 69 ± 25 64 ± 23*
Values expressed as mean ± SD
LV Left ventricular; RPP rate pressure product
* P \ 0.01 versus baseline, § P B 0.05 versus baseline
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Fig. 2 Serial changes in LAD coronary blood volume flow at
baseline and at 1 and 6 months after ASA, P \ 0.01 for trend
-10000 -5000 0 5000
-100
-75
-50
-25
0
25
p = 0.02
r = 0.83
∆  LVRPP
(mmHg • heart rate • min-1 )
∆
LA
D
 C
or
on
ar
y 
Bl
oo
d 
Fl
ow
(m
L •
 
m
in
-
1 )
Fig. 3 Correlation between the changes in LVRPP and LAD
coronary blood flow
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decrease of coronary blood flow was associated with a
larger decrease of the LVOT pressure gradient
(P = 0.01 for trend) and LVRPP (P \ 0.01 for trend).
Figure 3 graphically displays the linear regression
analysis between the change in LVRPP and LAD
coronary flow at 1 month follow-up (r = 0.83,
P = 0.02).
Coronary blood flow was not influenced by the
amount of ethanol administered during the ASA
procedure or cardiac enzyme release, although CE-
infarct size tended to modulate the blood flow
changes over time (P = 0.12). In addition, changes
in myocardial mass did not exert influence on the
observed flow changes.
Discussion
This is the first study that used CMR coronary flow
quantification, using phase-contrast velocity mea-
surements, to evaluate the effects of ASA on
coronary blood flow in symptomatic patients with
HOCM. Our data revealed a significant reduction of
resting LAD coronary artery blood flow during the
ensuing months of follow-up. We additionally
explored the role of changes in hemodynamics and
scar size induced by ablation therapy in relation to the
observed changes in coronary blood flow over time.
Resting coronary blood flow is adjusted at the
microvascular level in response to varying demand
through autoregulation of the coronary microcircula-
tion [14]. As heart rate and LV end-systolic cavity
pressure are the major determinants of the energy
requirement of the myocardium, these loading con-
ditions primarily dictate the level of basal coronary
blood flow [15]. The latter holds true under physio-
logical as well as pathophysiological conditions, such
as in patients with HCM [10]. In the present study,
alcohol ablation significantly reduced the hemody-
namic loading conditions, i.e., LVRPP. These
changes were solely determined by the reduction in
LVOT pressure gradient as heart rate and arterial
blood pressure were unaffected by the procedure. As
hypothesized, the changes in coronary blood flow
were directly related to these alterations in loading
conditions. These observations are in line with
Cannon et al. [16] who elegantly demonstrated a
reduction of great cardiac vein flow as well as global
myocardial oxidative metabolism 6 months after
surgical myectomy in symptomatic HOCM patients.
Similar to the present findings, these changes were
directly governed by the magnitude of outflow tract
pressure gradient relief. More recently, using cardiac
positron emission tomography, Jo¨rg-Ciopor et al. [17]
revealed a lower perfusion per grams of septal tissue
after surgical myectomy compared with medically
treated patients. Moreover, Rajappan et al. [18] have
shown that these physiological flow changes can also
be observed after gradient reduction through valve
replacement in patients with aortic valve stenosis.
The fundamental approach of alcohol ablation is
based on artificially inducing a fairly large myocar-
dial infarct in the hypertrophied myocardial septum
[8]. The procedure itself results in obliteration of a
septal branch of the LAD [6]. Furthermore, the
generated scar is metabolically inactive relative to the
previous myocardium subtended by the sacrificed
coronary artery [19]. As the current flow measure-
ments were presumably performed proximal to the
ablation site of the LAD, just distal to the junction of
the left main coronary artery and circumflex, these
conditions in theory are expected to influence coro-
nary blood flow. Nonetheless, a clear relationship
between CE-estimated infarct size and changes in
coronary blood flow could not be established,
although a trend was observed (P = 0.12). It there-
fore appears, that the reduction in coronary blood
flow is primarily instigated by altered LV loading
conditions as opposed to the induction of metaboli-
cally inactive myocardial scar tissue. The lack of
impact of scar on coronary blood flow is not well
understood and requires further investigation.
Regardless of the underlying mechanisms that are
responsible for the observed decrease in coronary
blood flow, the observation is important from a
pathophysiological point of view. The occurrence of
coronary microvascular dysfunction in HCM has
been firmly established and shown to be of important
prognostic relevance [20]. The reduction in loading
conditions by ASA and the concomitant reduction in
basal coronary flow could result in enhanced coro-
nary flow reserve. In other words, relief of resting
loading conditions may result in less frequent
episodes of ischemia for a given level of exertion,
and could explain the reported reduction for anginal
symptoms after treatment, and may ultimately con-
tribute to the suggested beneficial effects on
prognosis [6, 21]. Unfortunately, hyperemic LAD
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flow was not determined in the present study and
therefore the postulated enhancement of flow reserve
remains to be investigated. Preliminary data from
Soliman et al. [22], however, does suggest an
increase in flow reserve after septal alcohol ablation.
Limitations
Only a limited number of patients with HOCM were
studied, and the results should be interpreted with
care. Nevertheless, the coronary flow data convinc-
ingly indicate significant changes in coronary blood
flow in the LAD coronary artery after ASA.
The single breath-hold phase contrast velocity
quantification technique used in this study has impor-
tant limitations. First, it requires a long breath-hold
(20–30 s), which is difficult to obtain in every patient.
Second, the position of the breath-holding may vary,
which can result in a different image position from the
originally planned. Third, the technique has a large
acquisition window which results in some image
blurring because of cardiac motion [23]. Newer
techniques such as the use of spiral imaging reduced
this acquisition window and will result in a higher
accuracy [24], but this could not be achieved on the
system used. The slice thickness (5.5 mm) is not likely
to importantly affect the through plane velocity
measurement, because the imaged plane was posi-
tioned perpendicular to a relative straight segment of
the proximal left anterior descending coronary artery.
Fourth, the in-plane spatial resolution of the CMR
acquisition is limited with respect to the vessel
diameter, which is expected to cause variability on
the cross-sectional area assessment, and thereby on the
volume flow. These methodological issues prohibit its
use in routine clinical practice and results in unsuc-
cessful measurements in a substantial number of
patients. Clearly, this technique is not ready for
clinical use but can be useful for research purposes,
as presented in the current manuscript. Moreover, the
same methodology was used before and after septal
ablation. Attention was given to position the CMR
slice-position in an identical position within the left
anterior descending coronary artery. Thus, by using
each patient as his own control, errors in methodology
are expected to remain constant and thus allow valid
observation of the impact of the ablation procedure on
coronary artery flow.
In conclusion, we demonstrated that the reduction
of the LVOT pressure gradient by alcohol septal
ablation in symptomatic patients with HOCM was
accompanied by a significant decrease in left anterior
descending coronary resting blood flow. No signifi-
cant correlation was found between the artificially
induced septal myocardial infarct size and the reduc-
tion in coronary blood flow over time. These findings
support the hypothesis that diminished loading con-
ditions after successful relief of the LVOT pressure
gradient decreases the oxygen utilization and conse-
quently, coronary blood flow after ASA.
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